NASDAQ:FUSN

Fusion Pharmaceuticals News Headlines

$4.00

+0.18 (+4.71%)

(As of 05/13/2022 06:55 PM ET)

Add

Compare

Today's Range: $3.82
▼
$4.08
50-Day Range: $3.82
▼
$7.86
52-Week Range: $3.71
▼
$10.40

Volume: 3,900 shs
Average Volume: 38,846 shs
Market Capitalization: $173.37 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: -0.66

Get Fusion Pharmaceuticals News Delivered to You Automatically

Media Mentions By Week

Fusion Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FUSN
News Sentiment
▼
0.53

0.48
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FUSN Articles
This Week
▼
18

1
▲
FUSN Articles
Average Week

Fusion Pharmaceuticals (NASDAQ:FUSN) News Headlines Today

Source

Source	Headline
	Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) to Post Q1 2023 Earnings of ($0.46) Per Share, Wedbush Forecasts americanbankingnews.com - May 13 at 3:42 AM
	Wedbush Lowers Fusion Pharmaceuticals (NASDAQ:FUSN) Price Target to $19.00 americanbankingnews.com - May 12 at 4:48 AM
	Fusion Pharmaceuticals GAAP EPS of -$0.46, revenue of $0.59M seekingalpha.com - May 12 at 1:14 AM
	Fusion Pharmaceuticals to Present at the Guggenheim Securities Radiopharmaceuticals Day finance.yahoo.com - May 11 at 8:13 PM
	Fusion Pharmaceuticals Announces First Quarter 2022 Financial Results and Clinical Program Updates finance.yahoo.com - May 10 at 7:44 AM
	Fusion Pharmaceuticals to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference finance.yahoo.com - April 26 at 7:10 PM
	Fusion Pharmaceuticals (NASDAQ:FUSN) Rating Lowered to Hold at Zacks Investment Research americanbankingnews.com - April 22 at 1:28 AM
	Further weakness as Fusion Pharmaceuticals (NASDAQ:FUSN) drops 19% this week, taking one-year losses to 30% finance.yahoo.com - April 20 at 1:23 PM
	Fusion Pharmaceuticals GAAP EPS of -$0.40 beats by $0.09, revenue of $0.6M seekingalpha.com - March 17 at 4:49 PM
	Fusion Pharmaceuticals Announces Fourth Quarter 2021 Financial Results and Clinical Program Updates finance.yahoo.com - March 17 at 4:49 PM
	We're Not Very Worried About Fusion Pharmaceuticals' (NASDAQ:FUSN) Cash Burn Rate finance.yahoo.com - February 19 at 1:13 PM

	Fusion Pharmaceuticals grants stock options to one employee seekingalpha.com - February 9 at 1:20 PM
	Fusion Pharmaceuticals to Present at the B. Riley Securities 2022 Virtual Oncology Conference finance.yahoo.com - January 21 at 10:17 AM
	Fusion Pharma collaborates with Pepscan to develop peptide-based radiopharmaceuticals seekingalpha.com - January 11 at 12:49 PM
	Fusion Pharmaceuticals Announces Research Collaboration with 48Hour Discovery to Develop Peptide-Based Radiopharmaceuticals finance.yahoo.com - January 11 at 12:49 PM
	Fusion Pharmaceuticals Announces Research Collaboration with Pepscan to Develop Peptide-Based Radiopharmaceuticals finance.yahoo.com - January 11 at 12:49 PM
	Fusion Pharmaceuticals announces nomination of first TAT candidate under AstraZeneca tie-up seekingalpha.com - January 10 at 7:14 PM
	Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development finance.yahoo.com - January 10 at 7:14 PM
	What Type Of Shareholders Make Up Fusion Pharmaceuticals Inc.'s (NASDAQ:FUSN) Share Registry? nasdaq.com - December 24 at 1:59 PM
	Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results and Clinical Program Update finance.yahoo.com - November 9 at 11:04 AM
	Fusion Pharmaceuticals Appoints Industry Veteran Christopher Leamon, Ph.D., as Chief Scientific Officer finance.yahoo.com - November 2 at 7:32 PM
	Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting its FPI-1966 and FPI-2059 Targeted Alpha Therapies finance.yahoo.com - October 20 at 8:27 PM
	Fusion Pharmaceuticals Appoints Mohit Rawat as President and Chief Business Officer finance.yahoo.com - September 28 at 10:25 PM
	Here's Why We're Not Too Worried About Fusion Pharmaceuticals' (NASDAQ:FUSN) Cash Burn Situation nasdaq.com - September 25 at 4:28 PM
	Fusion Pharmaceuticals To Present At The 2021 Cantor Fitzgerald Virtual Global Healthcare Conference finance.yahoo.com - September 23 at 8:42 PM
	Fusion Pharmaceuticals Appoints Eric S. Hoffman, Ph.D. as Senior Vice President, Business Development finance.yahoo.com - September 21 at 12:13 PM
	Fusion Pharmaceuticals to Participate in Upcoming Investor Conferences finance.yahoo.com - September 2 at 4:17 PM
	We Think Fusion Pharmaceuticals (NASDAQ:FUSN) Can Afford To Drive Business Growth finance.yahoo.com - August 23 at 3:24 PM
	Fusion Pharmaceuticals and TRIUMF Announce Expanded R&D Collaboration for Actinium Supply Production finance.yahoo.com - August 12 at 4:57 PM
	Fusion Pharmaceuticals Inc. barrons.com - August 11 at 10:54 PM
	Fusion Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Update finance.yahoo.com - August 10 at 8:29 AM
	Fusion Pharmaceuticals to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference finance.yahoo.com - August 5 at 7:22 PM
	Fusion Warms to FDA Nod baystreet.ca - July 29 at 1:25 PM

	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - July 7 at 12:53 PM
	Stock Alert: Fusion Pharma Jumps 15% markets.businessinsider.com - June 15 at 5:28 PM
	Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from its Single-Dose Portion of the Phase 1 Study of FPI-1434 finance.yahoo.com - June 14 at 7:59 PM
	Fusion Pharmaceuticals Appoints Isabelle Dussault, Ph.D. as Senior Vice President, Research finance.yahoo.com - June 7 at 6:32 PM
	Fusion Pharmaceuticals Inks Manufacturing Deal with McMaster University nasdaq.com - June 3 at 1:27 PM
	Fusion Pharmaceuticals Enters into Agreement to Build Radiopharmaceutical Manufacturing Facility finance.yahoo.com - June 2 at 12:54 PM
	Fusion Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference finance.yahoo.com - May 27 at 5:32 PM
	What Kind Of Shareholders Hold The Majority In Fusion Pharmaceuticals Inc.'s (NASDAQ:FUSN) Shares? finance.yahoo.com - May 25 at 12:30 PM
	Fusion Pharmaceuticals Announces First Quarter 2021 Financial Results and Business Update finance.yahoo.com - May 11 at 7:53 AM
	Fusion Pharma Shares Move Higher After Trial Collab With Merck For IGF-1R-Expressing Cancer Study finance.yahoo.com - May 6 at 4:57 PM
	Fusion, Merck To Evaluate Fusion's Targeted Alpha Therapy In Combination With Merck's KEYTRUDA nasdaq.com - May 6 at 11:57 AM
	Fusion Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate Fusion's Targeted Alpha Therapy (TAT) in Combination with Merck's KEYTRUDA® (pembrolizumab) in Patients With Solid Tumors Expressing IGF-1R finance.yahoo.com - May 6 at 11:57 AM
	Fusion Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference finance.yahoo.com - April 14 at 9:58 AM
	Morgan Stanley Maintains Overweight on Fusion Pharmaceuticals, Lowers Price Target to $21 benzinga.com - April 7 at 2:02 PM
	Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors finance.yahoo.com - April 1 at 9:31 AM
	Are Insiders Buying Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Stock? finance.yahoo.com - March 26 at 9:42 AM
	Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results and Business Update finance.yahoo.com - March 25 at 8:14 AM

Get Fusion Pharmaceuticals News Delivered to You Automatically

This page was last updated on 5/16/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources